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doi:10.1Objective:After pneumonectomy, quality of life may be impaired in a proportion of patients because of the pres-
ence of symptoms causing severe limitations in daily activities. This is a prospective study on patients who have
undergone pneumonectomy for cancer, assessing quality of life modifications 6 months after surgery.
Methods: Beginning in August 2006, candidates for pneumonectomy had their quality of life assessed by the
European Organization for Research and Treatment of Cancer questionnaire (QLQ-C30þLC13) preoperatively
and at 1, 3, and 6 months after surgery. Poor quality of life at 6 months was defined as global health values 10% or
more below baseline values. The impact of several clinical variables was tested to discover predictors of poor
postoperative quality of life.
Results: Forty-one of the 50 patients enrolled in the study had a complete quality of life follow-up by January
2008, representing the population of the study. Sixmonths after pneumonectomy, global health showed aminimal
impairment in the whole population (baseline 60.4  26.5, at 6 months 56.3  24.2, P ¼ .15). Ten patients
(24.4%) were identified as having poor quality of life at 6 months. Age of 70 years or more was identified as
a significant risk factor for poor 6-month quality of life using multivariate analysis (odds ratio, 1.13; 95% con-
fidence interval, 1–1.26). The baseline global health score was the strongest predictor of postoperative global
health quality of life (odds ratio, 0.16; 95% confidence interval, 0.02–0.46; P ¼ .0086).
Conclusion: The overall quality of life after pneumonectomy was impaired in 25% of surviving patients at 6
months after surgery; thus, this aspect of recovery should be routinely discussed with patients before pneumonec-
tomy. Patients aged 70 years or more and those with low preoperative quality of life seem to be at risk for un-
satisfactory quality of life after surgery. (J Thorac Cardiovasc Surg 2010;139:49-52)Quality of life (QoL) is an important issue in oncology,1,2
not only defining the absence of disease but also measuring
physical, mental, and social well-being.3 Lung cancer sur-
gery may affect QoL,4,5 particularly when pneumonectomy
is required to obtain a radical resection.6 Apart from early
postoperative mortality,7-10 pneumonectomy has been re-
ported as being extremely detrimental in terms of QoL be-
cause of a greater incidence of dyspnea and a decrease in
physical functions, compared with patients undergoing
less dramatic resections.5 The impact of this impairment re-
mains controversial, and little information is present in the
literature. This study was designed to prospectively monitor
QoL after pneumonectomy, with the aim of defining the po-
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The Journal of Thoracic and CMATERIALS AND METHODS
A prospective observational study was designed to assess QoLmodifica-
tions during the first 6 months after surgery in a series of 50 consecutive pa-
tients undergoing pneumonectomy for lung cancer at the Thoracic Surgery
Department of the European Institute of Oncology. During the considered
period, a postoperative predicted forced expiratory volume in 1 second
less than 30% was considered a contraindication to pneumonectomy.
All patients for whom a pneumonectomy was planned were considered
eligible for the study, thereafter excluding those patients who underwent
lesser resections. QoL was assessed at admission and 6 months after surgery
by the administration of the Italian version of the European Organization for
Research and Treatment of Cancer questionnaire QLQ-C30 and the specific
lung module LC13. Raw scores were then standardized by linear transfor-
mation (range, 0–100). This questionnaire, widely used in thoracic oncol-
ogy, was chosen because of its focus on psycho-social aspects and typical
symptoms of patients treated by multimodality protocols, commonly used
in our practice.
The QLQ-C30 assessment focused on global QoL (global health [GH]),
functional domains (physical, role, emotional, cognitive, and social) and 8
symptoms (fatigue, nausea and vomiting, pain, dyspnea, insomnia, appetite
loss, constipation, and diarrhea). High scores for the functional and overall
QoL scales indicate a higher/healthier level. High scores for the symptom
scales represent a higher level of symptoms/problems. Missing data were
managed following European Organization for Research and Treatment
of Cancer Quality of Life Group guidelines:2,11 If at least half of the items
from the scale were answered, it was assumed that the missing items had
values equal to the average of those items that were present for that respon-
dent. Otherwise, the score was set to missing.
Comparison of QoL scores at baseline and at 6 months was performed by
the use of a t test for paired values. Impaired QoL at 6 months was defined as
a decrease in the GH status score of at least 10% from the baseline, because
lower differences are usually perceived by patients as minimal.12 Impairedardiovascular Surgery c Volume 139, Number 1 49
TABLE 1. Patient characteristics in the study population
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SDemographics N Mean ± SD Median Min-Max
Age (y) 41 60  9 61 36–77
50Abbreviation and Acronym
QoL ¼ quality of lifeRespiratory functions
FEV1 (%) 40 83.1  15.9 84.1 53–136
DLCO/Va (%) 40 91.2  16.4 89.7 59–126
Perfusion (%) of the
removed lung
39 35.2  10.1 35.0 6–56
Counts (%)
Gender Female 9 22.0%
Male 32 78.0%
Neoadjuvant treatment 21 53.8%
Surgical details
Right pneumonectomy 14 34.1%
Left pneumonectomy 27 65.8%
Extended procedure 8 19.5%
Postoperative complications
Reoperation 6 14.6%
ARDS 1 2.4%
Bronchial fistula 1 2.4%
SD, Standard deviation; ARDS, acute respiratory distress syndrome; FEV1, forced
expiratory volume in 1 second; DLCO/Va, diffusion capacity for carbon monoxide
adjusted for alveolar volume.
FIGURE 1. Six months after pneumonectomy, GH showed a minimal im-
pairment in the whole population (baseline 60.4 26.5, at 6 months 56.3
24.2, P ¼ .15).QoL at 6 months was considered as an outcome variable in a logistic regres-
sion model, using 10 covariates (age, sex, smoking status, American Society
of Anesthesiologists score, postoperative predicted forced expiratory vol-
ume in 1 second, neoadjuvant treatment, side of pneumonectomy, type of
pneumonectomy, postoperative complications, and adjuvant treatment).
The risk ratio and corresponding 95% confidence intervals were reported
for covariates considered clinically relevant or statistically significant at
the .05 significance level (Wald chi-square test) and then included in the
final multivariate model.
RESULTS
During a period of 13 months, 240 lung cancer resections
were performed, including 56 patients considered eligible
for pneumonectomy, 6 of whom underwent bronchoplasty
procedures and were thus excluded from the study. Three
patients died postoperatively, and 2 additional patients
died within 3 months of surgery. Items expressing GH status
remained missing for 4 patients and were excluded from the
analysis. The final study population comprised 41 patients.
Their clinical characteristics are expressed in Table 1.
Six months after pneumonectomy, GH showed no signif-
icant impairment in terms of the population as a whole (base-
line 60.4  26.5, at 6 months 56.3  24.2, P ¼ .15,
Figure 1). An increased negative effect was recorded in
the social functioning item (81.7  29.7 vs 71.9  31,
P ¼ .002, Table 2), the dyspnea score, the pain score, and
the nausea and vomiting score. Most patients also reported
increased financial difficulties after surgery (P ¼ .005). On
the other hand, patients’ emotional functioning (76.3 
18.3 vs 88  18.2, P< .0001) and cognitive functioning
(87.8  19 vs 95.1  13.6, P ¼ .008) were reported as
improved.
Ten patients (24.4%) were defined as having impaired
QoL at 6 months. Of the 4 factors identified at univariate
analysis (age, induction treatment, postoperative complica-
tions, and adjuvant treatment), only the factor of age 70
years or more was identified as a risk factor for the occur-
rence of 6-month impaired QoL (odds ratio 1.13; 95% con-
fidence interval, 1.1–2.6).
Analysis of the correlation between preoperative and 6-
month GH scores revealed a linear relationship for patients
with low QoL at baseline. The baseline GH score was the
strongest predictor of postoperative QoL (odds ratio, 0.16;
95% confidence interval, 0.02–0.46; P¼ .0086). The corre-
sponding receiver operating characteristic curve expresses
a notably high area under the curve estimate (0.92).
DISCUSSION
QoL should be routinely assessed when major surgery is
required in cancer treatment. This is particularly true in theThe Journal of Thoracic and Cardiovascular Surgecase of pneumonectomy, which is often performed after
neoadjuvant treatment (in cases of T4 tumors or minimal
N2 disease responding to chemotherapy at the European In-
stitute of Oncology) or before adjuvant therapy, when the
detrimental effects of a treatment on QoL have a cumulative
effect on subsequent treatments.
This series reported only minimal overall QoL impair-
ment after pneumonectomy, probably because of the balance
between the worsening of symptoms and the improvement
of psychologic well-being, due to the positive expectation
of having their cancer definitively cured by surgical inter-
vention.
Nevertheless, 1 of 4 patients registered a significant QoL
decrease. The cause of that decrease may be representedry c January 2010
TABLE 2. Comparison of preoperative and postoperative scores from the European Organization for Research and Treatment of Cancer
QLQ-C30 and LC-13 questionnaires
Questionnaire Before pneumonectomy Six months after pneumonectomy P value
EORTC QLQ-C30 Mean SD Mean SD
GH status/QoL
GH status QL2 60.4 26.5 56.3 24.2 .15
Functional scales
Physical functioning PF2 76.3 25.9 71.1 25.6 .82
Role functioning RF2 77.8 30.7 74.4 32.9 .09
Emotional functioning EF 76.3 18.3 88 18.2 <.001
Cognitive functioning CF 87.8 19 95.1 13.6 .008
Social functioning SF 81.7 29.7 71.9 31 .002
Symptom scales/items
Fatigue FA 25.3 24.8 29.5 24.7 .08
Nausea and vomiting NV 4.5 11.2 11 16.9 .02
Pain PA 18.7 31.4 29.7 31.5 <.001
Dyspnea DY 26 29.3 35.8 28.3 .38
Insomnia SL 18.3 30.1 14.6 26.9 .43
Appetite loss AP 13 20.9 18.7 23.6 .15
Constipation CO 17.1 22.5 11.4 19.2 .11
Diarrhea DI 4.9 14.1 4.1 11 .11
Financial difficulties FI 12.5 22.2 5.8 16.7 .005
EORTC LC13
Symptom scales/items
Dyspnea LCDY 20.2 20.6 32.5 20.2 <.001
Coughing LCCO 30 22.4 28.4 20.5 .80
Sore mouth LCSM 3.3 10.1 4.2 13.5 1
Dysphagia LCDS 5.8 16.7 10 18.8 .12
Peripheral neuropathy LCPN 7.5 14.1 5 14.2 .54
Alopecia LCHR 6.7 17.2 12.2 28.6 .24
Pain in chest LCPC 6.7 15.5 8.5 19.8 .56
Pain in arm or shoulder LCPA 7.5 20.6 15 26.1 .09
Pain in other parts LCPO 21.6 34.7 23.9 31.5 .84
EORTC, European Organization for Research and Treatment of Cancer; GH, global health; QoL, quality of life.
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Sby cardiopulmonary response to surgery, because that figure
is extremely close to the percentage of patients who failed to
increase their cardiac index after pneumonectomy (20%).13
It is reasonable to assume that impaired cardiac response
may translate into impaired QoL; thus, treating the first
would consequently improve the second. Unfortunately,
this interpretation remains speculative, as to date, no existing
evidence confirms this hypothesis.
As previously reported,14 no clinical parameter apart from
age was identified as a risk factor for QoL impairment 6
months after pneumonectomy. Analysis of score distribution
suggested that, in patients with low preoperative QoL, post-
operative QoL was not affected by pneumonectomy.
Patients with high QoL levels at baseline however, were
more likely to exhibit QoL impairments of unpredictable
nature.
An additional QoL issue is how to consider patients who
died within 6 months of pneumonectomy. These patients
were not included in our analysis and were registered as
having a QoL score of 0 because QoL cannot be expressed
without patients’ judgment. Nevertheless, these deaths areThe Journal of Thoracic and Cusually the final event in a rapid and progressive decline in
QoL, which usually remains unreported, constituting an
additional risk of which patients should be informed.
CONCLUSIONS
The overall QoL after pneumonectomy was impaired in
25% of cases, an aspect that should be routinely discussed
with patients before surgery. Patients aged 70 years or
more and those with low preoperative QoL seem to be at
highest risk for reduced QoL after surgery.
The authors thank Kendall Katze for reviewing the English ver-
sion of the article.
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